Co-Authors
This is a "connection" page, showing publications co-authored by Luca Richeldi and Antonio Gasbarrini.
Connection Strength
0.320
-
Evaluation of the lung microbiome as a therapeutic target in the management of idiopathic pulmonary fibrosis: role of antioxidant/antibiotic combination therapy. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6379-6386.
Score: 0.208
-
Sarilumab use in severe SARS-CoV-2 pneumonia. EClinicalMedicine. 2020 Oct; 27:100553.
Score: 0.057
-
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic. J Ultrasound. 2020 Dec; 23(4):449-456.
Score: 0.056